Literature DB >> 21424386

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.

Yan Zhang1, Jin Wang, Li-Mei Zhao, Wei Peng, Guo-Qing Shen, Ling Xue, Xiao-Xian Zheng, Xiao-Jing He, Chun-Yan Gong, Li-Yan Miao.   

Abstract

PURPOSE: The purpose of this study is to examine the association of HLA-B*1502 allele with CBZ-induced SJS/TEN in the mainland Han Chinese population.
METHODS: HLA-B*1502 genotyping with sequence-specific primer polymerase chain reaction (PCR-SSP) and PCR-sequencing based typing (PCR-SBT) was performed on 17 CBZ-induced SJS/TEN patients, 21 CBZ-tolerant controls, and 185 healthy controls recruited during 2008-2010.
RESULTS: HLA-B*1502 allele was present in 94.1% (16/17) of CBZ-SJS/TEN patients, 9.5% (2/21) of CBZ-tolerant patients, and 9.2% (17/185) of healthy controls. The risk of CBZ-induced SJS/TEN was significantly higher (P < 0.01) in the patients with HLA-B*1502. One CBZ-induced SJS patient tested negative for HLA-B*1502, and the test result showed HLA-B*3503/B*4601.
CONCLUSIONS: We found a strong association between HLA-B*1502 and CBZ-induced SJS/TEN in the Han Chinese population from central and northern China. Combined with previous studies of the southern Han Chinese subpopulation, our results suggest that HLA-B*1502 is strongly associated with CBZ-induced SJS/TEN in the whole Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424386     DOI: 10.1007/s00228-011-1009-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing.

Authors:  D Middleton; B R Hawkins; F Williams; A Meenagh; J Moscoso; J Zamora; A Arnaiz-Villena
Journal:  Tissue Antigens       Date:  2004-06

2.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

3.  Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.

Authors:  Celeste B L Man; Patrick Kwan; Larry Baum; Evelyn Yu; K M Lau; Alice S H Cheng; Margaret H L Ng
Journal:  Epilepsia       Date:  2007-05       Impact factor: 5.864

Review 4.  Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy.

Authors:  Maja Mockenhaupt
Journal:  J Dtsch Dermatol Ges       Date:  2009-02       Impact factor: 5.584

5.  Genomic dissection of population substructure of Han Chinese and its implication in association studies.

Authors:  Shuhua Xu; Xianyong Yin; Shilin Li; Wenfei Jin; Haiyi Lou; Ling Yang; Xiaohong Gong; Hongyan Wang; Yiping Shen; Xuedong Pan; Yungang He; Yajun Yang; Yi Wang; Wenqing Fu; Yu An; Jiucun Wang; Jingze Tan; Ji Qian; Xiaoli Chen; Xin Zhang; Yangfei Sun; Xuejun Zhang; Bailin Wu; Li Jin
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

6.  Typing of HLA-B*15 alleles using sequence-specific primers.

Authors:  N Yu; M Ohashi; S Alosco; M Salazar; K Cao; M Fernandez Vina; E J Yunis
Journal:  Tissue Antigens       Date:  1998-09

7.  Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Authors:  Wichittra Tassaneeyakul; Somsak Tiamkao; Thawinee Jantararoungtong; Pei Chen; Shu-Yi Lin; Wei-Hsuan Chen; Parinya Konyoung; Usanee Khunarkornsiri; Narong Auvichayapat; Kasemsin Pavakul; Kongkiat Kulkantrakorn; Charoen Choonhakarn; Siranun Phonhiamhan; Namfon Piyatrakul; Thiti Aungaree; Sunsanee Pongpakdee; Praphan Yodnopaglaw
Journal:  Epilepsia       Date:  2010-03-19       Impact factor: 5.864

8.  Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.

Authors:  B Rzany; O Correia; J P Kelly; L Naldi; A Auquier; R Stern
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

Review 9.  The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification.

Authors:  J C Roujeau
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

10.  Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population.

Authors:  S Saito; S Ota; E Yamada; H Inoko; M Ota
Journal:  Tissue Antigens       Date:  2000-12
View more
  32 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

2.  External quality assessment for laboratory testing of HLA-B*15:02 allele in relation to carbamazepine therapy.

Authors:  Guigao Lin; Kuo Zhang; Yanxi Han; Jiehong Xie; Jinming Li
Journal:  J Clin Lab Anal       Date:  2017-04-25       Impact factor: 2.352

3.  Screening for 392 polymorphisms in 141 pharmacogenes.

Authors:  Jason Yongha Kim; Hyun Sub Cheong; Tae-Joon Park; Hee Jung Shin; Doo Won Seo; Han Sung Na; Myeon Woo Chung; Hyoung Doo Shin
Journal:  Biomed Rep       Date:  2014-04-30

Review 4.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

Review 5.  The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review.

Authors:  Nahoko Kaniwa; Yoshiro Saito
Journal:  Ther Adv Drug Saf       Date:  2013-12

6.  PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Authors:  Julia M Barbarino; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2015-04       Impact factor: 2.089

Review 7.  Genotyping for severe drug hypersensitivity.

Authors:  Eric Karlin; Elizabeth Phillips
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

8.  Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China.

Authors:  Dan Sun; Chun-Hua Yu; Zhi-Sheng Liu; Xue-Lian He; Jia-Sheng Hu; Ge-Fei Wu; Bing Mao; Shu-Hua Wu; Hui-Hui Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

9.  HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population.

Authors:  Qinyuan Zhu; Yanzhou Zhang; Jiekun Xuan; Fanping Yang; Binbin Du; Sheng-An Chen; Sijia Yan; Menglin Jiang; Huizhong Zhu; Hao Xiong; Xiaoqun Luo; Qinghe Xing
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

10.  Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.

Authors:  Somsak Tiamkao; Jukrapope Jitpimolmard; Kittisak Sawanyawisuth; Suthipun Jitpimolmard
Journal:  Int J Clin Pharm       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.